Regencell Bioscience Holdings Limited (RGC)
$7.35-3.67%Close
BUYRECOVERY · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.6B
- Beta
- 1.43
- P/E (TTM)
- -517.61
- Short % float
- 3.80%
- Days to cover
- 7.3
- SI change
- -18.1%
- 1W
- +7.77%
- 1M
- +30.32%
- vs SPY 1W
- +6.61%
- vs SPY 1M
- +27.33%
Industry peers
FMP comparable companies · ranked by market cap
- MASIMasimo Corporation$9.4B$179.95
- AXSMSELLAxsome Therapeutics, Inc.$9.2BCRISISQ 34$179.25-1.02%
- NUVLBUYNuvalent, Inc.$9.1BBULLQ 42$123.96+0.00%
- CYTKSELLCytokinetics, Incorporated$8.2BCRISISQ 9$65.60+1.45%
- ATRSELLAptarGroup, Inc.$7.7BBEARQ 17$119.91-1.17%
- MRUSMerus N.V.$6.8B$90.00
- ABVXSELLAbivax S.A.$6.8BCRISISQ 57$92.88-1.01%
- RYTMSELLRhythm Pharmaceuticals, Inc.$6.4BBEARQ 20$92.83+1.27%
- GRFSSELLGrifols, S.A.$6.2BRECOVERYQ 5$7.31+0.67%
- STVNSELLStevanato Group S.p.A.$5.5BBEARQ 7$20.20+0.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RGC?
- LOPJLB’s latest quantitative signal on Regencell Bioscience Holdings Limited (RGC) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is RGC in?
- Regencell Bioscience Holdings Limited (RGC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Regencell Bioscience Holdings Limited (RGC) do?
- Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity d…